Astaxanthin 6 mg Explained: Antioxidant Benefits, Dose & What the Evidence Really Says

One capsule has a clear licensed antioxidant purpose. Skin, eye and exercise research belongs in a separate evidence layer—not on the label by implication.

QUICK ANSWER Biogenique Astaxanthin provides 6 mg of astaxanthin from whole Haematococcus pluvialis microalgae per capsule. Its Canadian licence authorizes one core purpose: a source of antioxidants that helps protect cells against oxidative damage caused by free radicals. That is not the same as a licensed promise for younger-looking skin, dry-eye treatment, better athletic performance or sun protection.

What is astaxanthin?

Astaxanthin is a red-orange carotenoid—a member of the pigment family that also includes beta-carotene and lutein. In this product, it comes from the whole microalga Haematococcus pluvialis. The product licence identifies the chemical as 3,3'-dihydroxy-beta,beta-carotene-4,4'-dione and lists one medicinal ingredient: 6 mg per oral capsule.

Those details matter because “astaxanthin” is not one universal supplement. Studies may use different sources, extracts, doses, carriers, combinations and treatment periods. A result from another preparation is research context—not automatic evidence for this exact bottle.

What exactly is in the Biogenique formula?

Medicinal ingredient: astaxanthin, 6 mg per capsule, sourced from whole Haematococcus pluvialis.
Non-medicinal ingredients on current artwork: hypromellose and microcrystalline cellulose.
Licensed adult dose: one capsule once daily.
Available bottle sizes: 60 capsules and 120 capsules; NPN 80136585.

Three evidence layers that should not be blended

Evidence layer	What can be said	What cannot be inferred
Licensed product claim	Source of antioxidants that helps protect cells against oxidative damage caused by free radicals.	No licensed skin, eye, exercise-performance, recovery or sunscreen claim.
Ingredient research	Human trials and reviews have explored skin measures, eye-related outcomes, oxidative-stress markers and exercise recovery.	A study on another formula does not prove the same effect for this product.
Quality documentation	The licence and artwork verify formula, dose and required risk statements.	They do not prove “better absorption,” “more efficient,” or every-batch purity and potency claims.

What does “antioxidant protection” mean?

Free radicals are reactive molecules produced through normal metabolism and environmental exposures. When oxidant production and antioxidant defences are out of balance, oxidative damage can affect cellular lipids, proteins and DNA. An antioxidant can participate in chemical pathways that limit some of those reactions. The licensed wording stays at that general cellular level.

It does not establish that astaxanthin prevents a disease, reverses ageing or outperforms another nutrient in people. Comparisons such as “thousands of times stronger than vitamin C” usually come from specific laboratory assays. Different assays measure different reactions, so their ratios cannot be converted into a clinical ranking or a dose-equivalence statement.

A 2022 systematic review and meta-analysis of randomized trials reported mild reductions in some oxidative-stress and inflammation biomarkers. Biomarker movement can support biological plausibility, but it is not the same as demonstrating a noticeable health outcome or proving efficacy for one commercial product.

What does the skin evidence show?

Skin research is promising, but the headline needs restraint. A 2021 systematic review and meta-analysis pooled eight randomized controlled studies of oral astaxanthin capsules and considered a separate topical trial. It reported signals for improved moisture and elasticity and fewer visible wrinkles. The evidence base was still small, and products, doses, durations and methods varied.

That supports wording such as “researchers have studied astaxanthin for skin appearance.” It does not support promising “glass skin,” claiming this capsule treats skin ageing, or implying it replaces sunscreen. Sun protection still means proven measures such as shade, clothing and an appropriately labelled sunscreen; an oral antioxidant is not a substitute.

What about eyes and screen fatigue?

Health Canada’s current Haematococcus pluvialis monograph allows applicants to seek certain optional eye-strain, eye-fatigue and ocular-health claims within specified adult dose ranges. But a monograph is a licensing pathway, not the licence for every product that uses the ingredient. NPN 80136585 does not carry those optional eye claims.

That distinction prevents a common marketing shortcut: turning an ingredient’s possible monograph claim into an approved claim for a product that never received it. Persistent dry-eye symptoms, pain, redness or vision changes deserve assessment; this supplement should not be presented as a dry-eye treatment.

Does astaxanthin improve exercise or recovery?

The newest broad review is more useful than a dramatic single study. A 2026 systematic review and meta-analysis included 24 randomized controlled trials. It found no significant improvement in VO2max, time-trial performance or maximal workload or power. Creatine kinase favoured astaxanthin, while another recovery marker showed substantial heterogeneity; the authors called for larger, standardized trials.

So “may influence some recovery biomarkers” is a fair research summary. “Boosts endurance,” “improves performance” or “speeds recovery” would overstate the current evidence and are not licensed claims for this product.

How to take this exact 6 mg product

The licensed direction is for adults 18 years and older: take one capsule once daily. A 60-capsule bottle therefore contains 60 daily servings. A 120-capsule bottle contains 120 daily servings, but the licence directs users to consult a health-care practitioner for use beyond three months. The licence does not specify a meal requirement or a morning-versus-evening schedule.

Consult a health-care practitioner before use if you are pregnant or breastfeeding.
Consult a health-care practitioner if you intend to continue beyond three months.
Follow the current label; more is not automatically better, and research doses should not replace licensed directions.

The quality question the website cannot answer alone

The reviewed product files verify the licence, formula and label. No finished, product-specific, current-lot Astaxanthin certificate of analysis was located. The issuance letter also states that the finished-product specifications and mock labels were not reviewed for accuracy as part of the licence decision, and that marketing terms require evidence held by the licensee.

Accordingly, the material reviewed does not substantiate claims that every batch has confirmed potency, heavy-metal and microbial safety, “better absorption,” or greater efficiency than standard alternatives. A useful COA would match the current lot and expiry and report identity, assay or potency, microbiology, and relevant contaminant results. General laboratory language is not a substitute for that lot-specific record.

Frequently asked questions

Is 6 mg a high dose?

It is the licensed daily amount for this product. Health Canada’s current ingredient monograph allows wider adult ranges for some claims, but that does not make a higher dose better or turn those other claims into claims for NPN 80136585.

Is astaxanthin better than vitamin C?

There is no clinically meaningful “times stronger” conversion. Astaxanthin and vitamin C differ in structure, location in the body and the laboratory systems used to test them. An in-vitro antioxidant ratio is not a head-to-head human outcome.

Can astaxanthin replace sunscreen?

No. This product is not licensed as an oral sunscreen and should not be marketed as one. Use established sun-protection measures and follow professional advice for skin concerns.

Can I take it for dry eye?

The product’s licence does not include a dry-eye or ocular-health claim. Do not use an ingredient monograph or a small study to reclassify the supplement as a treatment. Seek assessment for persistent or concerning eye symptoms.

The bottom line

Biogenique Astaxanthin has a precise, supportable story: 6 mg from whole Haematococcus pluvialis, once daily, as a licensed source of antioxidants that helps protect cells against oxidative damage caused by free radicals. Skin and recovery findings are interesting but not product-equivalent; optional eye claims in the ingredient monograph are not on this NPN. Keep the article useful by showing those boundaries, retaining the three-month and pregnancy cautions, and obtaining a current lot-specific COA before publishing broad quality or absorption claims.

PUBLICATION GATE Retain only the licensed antioxidant wording as the product benefit. Remove or qualify skin, eye, recovery, sunscreen, “stronger than vitamin C,” better-absorption, comparative-efficiency, potency and every-batch claims. Surface the one-capsule dose, three-month consultation limit and pregnancy/breastfeeding caution. Obtain a current product-specific COA before making lot-quality claims.

Product link

View Biogenique Astaxanthin

Sources

Educational information only; not medical advice. Natural health product claims, directions and risk statements are product- and licence-specific. Always read the current label.